Category:
Prophylactic Biological Products
A fixed-dose combination of Montelukast (C25H28ClNO3S, CAS 159789-10-5) and Levocetirizine (C17H19ClN2O3, CAS 149667-93-6). Manufactured via precision crystallization and compression to ensure bioequivalence for respiratory management.
Contraindicated in severe hepatic impairment. Store below 30°C in dry conditions. Monitor neuropsychiatric events associated with montelukast exposure.